The fact
The treatment targets adults and adolescents aged 12 and over who have failed other therapies.
It provides an alternative to existing treatments, often limited in effectiveness.
Click the link to read an article on the topic:
The treatment targets adults and adolescents aged 12 and over who have failed other therapies.
It provides an alternative to existing treatments, often limited in effectiveness.